Gastric Balloon Market 2019 | New Business Opportunities and Growth Segmented By Prominent Players like Apollo Endosurgery, Allurion Technologies, Helioscopie Medical Implants, Obalon Therapeutics, ReShape Lifesciences, Silimed, and Spatz

The global gastric balloon market accounted to US$ 62.9 Mn in 2017 and is expected to grow at a CAGR of 9.7% during the forecast period 2018 - 2027, to account to US$ 152.1 Mn by 2027.

The gastric balloon market report aims to provide a 360-degree view of the market in terms of cutting-edge technology, key developments, drivers, restraints and future trends with impact analysis of these trends on the market for short-term, mid-term and long-term during the forecast period. Further, the report also covers key players profiling with detailed SWOT analysis, financial facts and key developments of products/service from the past three years.

Get PDF sample copy: https://www.theinsightpartners.com/sample/TIPRE00003016/?opr-ss

The market for gastric balloon is expected to grow due to rising cases of obesity as well as increasing preference for minimally invasive surgical method. In addition, growth of the market in emerging nations is likely to have a positive impact on the growth of the market in the coming years.

The major players operating in the gastric balloon market include, Apollo Endosurgery, Inc., Allurion Technologies ENDALIS, Helioscopie Medical Implants, LEXEL SRL, MEDSIL, Obalon Therapeutics, Inc., ReShape Lifesciences, Inc., Silimed, and Spatz FGIA, Inc., among others.

Approvals the are prominent parameters by industry players leading strategies undertaken by key market players. For instance, during December, 2018, Obalon received FDA approval of the Obalon Navigation System, which eliminates the need to use x-ray when placing the Obalon Balloon System. The Obalon Navigation System and Touch Inflation Dispenser are expected to be commercially available during the first quarter of 2019 in the United States.

Global gastric balloon market, based on product was segmented as, single gastric balloons, dual gastric balloons and triple gastric balloons. In 2018, the single gastric balloon held the largest share of the market, by product. Additionally, the segment is also expected to grow at the fastest CAGR during the forecast period owing to better benefits offered as compared to the dual and triple gastric balloon, also the implantation of a single balloon causes less discomfort, leading to its rising preference.

Buy the complete report @ https://www.theinsightpartners.com/buy/TIPRE00003016/?opr-ss

Strategic Insights

Approvals and agreements were observed as the most adopted strategy in global gastric balloon industry. Few of the recent product launch and collaboration are listed below;

2018: In April, 2018, Apollo received approval from the Saudi Food and Drug Authority (SFDA) for the ORBERA365 Managed Weight Loss System. This approval enables the reach of ORBERA365 into the largest bariatric market in the Middle East with over 15,000 procedures performed per year.

2017: In November, 2017, Obalon and Sono Bello entered an agreement. Through the agreement the Obalon Balloon System would be used for non-surgical weight loss in Sono Bello centers across the US.

2015: In December 2015, Allurion received a CE mark allowing sale of the product in the European Union. The product has been made available in the weight loss centers in France, Italy and the United Kingdom.

Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com
Web: https://www.theinsightpartners.com/

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

This release was published on openPR.